Efficacy and Safety of Antiretroviral Therapy Initiated One Week after Tuberculosis Therapy in Patients with CD4 Counts < 200 Cells/μL: TB-HAART Study, a Randomized Clinical Trial

BACKGROUND: Given the high death rate the first two months of tuberculosis (TB) therapy in HIV patients, it is critical defining the optimal time to initiate combination antiretroviral therapy (cART). METHODS: A randomized, open-label, clinical trial comparing efficacy and safety of efavirenz-based...

Descripción completa

Detalles Bibliográficos
Autores principales: Amogne, Wondwossen, Aderaye, Getachew, Habtewold, Abiy, Yimer, Getnet, Makonnen, Eyasu, Worku, Alemayhu, Sonnerborg, Anders, Aklillu, Eleni, Lindquist, Lars
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4429073/
https://www.ncbi.nlm.nih.gov/pubmed/25966339
http://dx.doi.org/10.1371/journal.pone.0122587

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4429073/
https://www.ncbi.nlm.nih.gov/pubmed/25966339
http://dx.doi.org/10.1371/journal.pone.0122587

Ejemplares similares